Spiriva Respimat Approval History
FDA Approved: Yes (First approved September 24, 2014)
Brand name: Spiriva Respimat
Generic name: tiotropium bromide
Dosage form: Inhalation Spray
Company: Boehringer Ingelheim Pharmaceuticals, Inc.
Treatment for: Asthma, Maintenance, COPD, Maintenance
Spiriva Respimat (tiotropium bromide) is a long-acting muscarinic antagonist (LAMA) indicated for the long-term, maintenance treatment of chronic obstructive pulmonary disease (COPD) and asthma.
Development History and FDA Approval Process for Spiriva Respimat
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.